Mitchell W. Krucoff
#135,709
Most Influential Person Now
Mitchell W. Krucoff's AcademicInfluence.com Rankings
Mitchell W. Krucoffphilosophy Degrees
Philosophy
#6840
World Rank
#9947
Historical Rank
Logic
#3942
World Rank
#5176
Historical Rank

Download Badge
Philosophy
Why Is Mitchell W. Krucoff Influential?
(Suggest an Edit or Addition)Mitchell W. Krucoff's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions (2007) (5088)
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium (2011) (3111)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1784)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1700)
- Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. (2014) (1564)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1192)
- Outcomes of anatomical versus functional testing for coronary artery disease. (2015) (1126)
- Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium† (2010) (975)
- Incidence (1931) (868)
- Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. (2011) (842)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). (2012) (642)
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI. (2019) (539)
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study (2013) (532)
- Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young (2004) (512)
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. (2016) (406)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (388)
- Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. (1997) (387)
- Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. (2016) (365)
- Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial (2005) (341)
- Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. (2005) (322)
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention (2019) (293)
- Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. (2001) (284)
- Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery for Patients With Medically Refractory Myocardial Ischemia and Risk Factors for Adverse Outcomes With Bypass: A Multicenter, Randomized Trial (2001) (277)
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018) (268)
- Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk (2019) (266)
- In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. (2009) (253)
- Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). (2015) (243)
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018) (228)
- Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. (1986) (226)
- A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. (2014) (221)
- Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. (1995) (218)
- The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. (2009) (187)
- Best practices for transradial angiography and intervention: A consensus statement from the society for cardiovascular angiography and intervention's transradial working group (2014) (186)
- Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. (1993) (173)
- Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study (2005) (173)
- Continuous 12‐Lead ST‐Segment Recovery Analysis in the TAMI 7 Study Performance of a Noninvasive Method for Real‐Time Detection of Failed Myocardial Reperfusion Detection of Failed Myocardial Reperfusion (1993) (168)
- Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium. (2015) (164)
- Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. (1996) (164)
- The Learning Curve for Transradial Percutaneous Coronary Intervention Among Operators in the United States: A Study From the National Cardiovascular Data Registry (2014) (163)
- Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. (2000) (157)
- Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). (2005) (136)
- Thrombosis and drug-eluting stents: an objective appraisal. (2007) (129)
- Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis (2012) (128)
- A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. (2008) (123)
- Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. (2002) (122)
- Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the left anterior descending coronary artery. (1988) (122)
- Percutaneous atrial Septal Occluder devices and cardiac erosion: A review of the literature (2012) (120)
- PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial. (2014) (120)
- Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. (1998) (119)
- The truth and consequences of the COURAGE trial. (2007) (119)
- Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). (2007) (119)
- Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative. (2009) (111)
- The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion. (1990) (111)
- Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. (1996) (109)
- A Reevaluation of the Costs of Heart Failure and Its Implications for Allocation of Health Resources in the United States (2014) (108)
- AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society o (2005) (105)
- Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. (2020) (104)
- Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention. (2007) (104)
- Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. (2016) (103)
- Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). (2007) (102)
- Effect of Supersaturated Oxygen Delivery on Infarct Size After Percutaneous Coronary Intervention in Acute Myocardial Infarction (2009) (100)
- Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilot. (2001) (95)
- Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. (2016) (94)
- Multilead ST-segment monitoring in patients with acute coronary syndromes: a consensus statement for healthcare professionals. ST- Segment Monitoring Practice Guideline International Working Group. (1999) (94)
- Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study). (2004) (90)
- Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study. (2012) (88)
- Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). (2007) (88)
- Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th (2001) (83)
- Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. (2014) (81)
- Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. (1998) (80)
- Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (77)
- Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries. (2002) (77)
- Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology. (2011) (76)
- Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. (1990) (75)
- Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. (2017) (75)
- Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study. (2006) (74)
- The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. (2015) (72)
- Novel oral anticoagulants and reversal agents: Considerations for clinical development. (2015) (71)
- Ventricular arrhythmias during reperfusion. (1986) (70)
- Intracoronary ultrasound evaluation of interventional technologies. (1991) (68)
- Stability of multilead ST-segment "fingerprints" over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion. (1988) (68)
- Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. (2005) (68)
- Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). (2013) (67)
- ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. (2000) (66)
- The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease. (2016) (66)
- Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. (2020) (65)
- Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction. (2016) (64)
- Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials (2015) (64)
- Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. (2002) (64)
- Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. (2021) (61)
- Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial in (2009) (61)
- Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium. (2015) (59)
- Electrocardiographic differentiation of the ST-segment depression of acute myocardial injury due to the left circumflex artery occlusion from that of myocardial ischemia of nonocclusive etiologies. (1997) (59)
- A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study). (2011) (59)
- Paced QRS duration as a predictor for clinical heart failure events during right ventricular apical pacing in patients with idiopathic complete atrioventricular block: results from an observational cohort study (PREDICT‐HF) (2013) (58)
- Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention (2015) (57)
- Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study Group. (1994) (54)
- Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. (2016) (54)
- Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative (2018) (52)
- Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. (1998) (52)
- Instrumentation and practice standards for electrocardiographic monitoring in special care units. A report for health professionals by a Task Force of the Council on Clinical Cardiology, American Heart Association. (1989) (49)
- Identification of high-risk patients with silent myocardial ischemia after percutaneous transluminal coronary angioplasty by multilead monitoring. (1988) (49)
- Bridging Unmet Medical Device Ecosystem Needs With Strategically Coordinated Registries Networks. (2015) (49)
- ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. (2008) (47)
- Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. (2016) (47)
- Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction. (2008) (45)
- QT prolongation and dispersion in myocardial ischemia and infarction. (1998) (43)
- Acute detection of ST-elevation myocardial infarction missed on standard 12-Lead ECG with a novel 80-lead real-time digital body surface map: primary results from the multicenter OCCULT MI trial. (2009) (42)
- Postmarket evaluation of breakthrough technologies. (2008) (41)
- Autopsy validation study of the academic research consortium stent thrombosis definition. (2011) (41)
- Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis. (1999) (40)
- Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective. (2012) (39)
- Computer-assisted ST-segment monitoring: experience during and after brief coronary occlusion. (1987) (39)
- The touch that heals: the uses and meanings of touch in the clinical encounter. (2008) (39)
- Pre-hospital synthesized 12-lead ECG ischemia monitoring with trans-telephonic transmission in acute coronary syndromes: pilot study results of the ST SMART trial. (2004) (39)
- Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration. (2011) (38)
- Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: Results of the Study of Access Site for Enhancement of Percutaneous Coronary Intervention for Women quality-of-life substudy. (2015) (37)
- Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction. (2007) (37)
- Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty. (2001) (36)
- A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT). (2000) (36)
- Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias. (2008) (35)
- Simultaneous ST-segment measurements using standard and monitoring-compatible torso limb lead placements at rest and during coronary occlusion. (1994) (35)
- Electrocardiographic assessment for therapeutic proteins--scientific discussion. (2010) (34)
- Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2015) (34)
- The academic research consortium governance charter. (2011) (34)
- Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. (2010) (34)
- Usefulness of frequent arrhythmias after epicardial recanalization in anterior wall acute myocardial infarction as a marker of cellular injury leading to poor recovery of left ventricular function. (2003) (34)
- Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model. (2021) (33)
- Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. (2016) (33)
- Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the right and left circumflex coronary arteries. (1989) (33)
- Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model. (2006) (33)
- Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. (2004) (32)
- Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study (2009) (32)
- A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVA (2015) (31)
- Acute results, complications, and effect of lesion characteristics on outcome with the solid‐state, pulsed‐wave, mid‐infrared laser angioplasty system: Final multicenter registry report (1998) (30)
- Periprocedural myocardial ischemia in patients with severe symptomatic coronary artery disease undergoing endoscopy: prevalence and risk factors. (1995) (30)
- Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis. (2012) (30)
- Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary int (2010) (30)
- Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. (2004) (29)
- Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion. (2004) (29)
- 3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation. (2021) (28)
- Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. (2021) (28)
- The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing. (2010) (27)
- More Complete and Stable Reperfusion with Platelet IIb/IIIa Antagonism Plus Thrombolysis for AMI: The PARADIGM Trial (1996) (27)
- Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database. (2010) (27)
- Quantitative and qualitative ST segment monitoring during and after percutaneous transluminal coronary angioplasty. (1990) (27)
- A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of (1999) (27)
- Treatment of long coronary artery narrowings with long angioplasty balloon catheters. (1993) (26)
- Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion. (2005) (26)
- Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel. (2020) (25)
- Quantification of ST-segment changes during coronary angioplasty in patients with left bundle branch block. (1991) (25)
- Comparison of Electrocardiogram and Intrathoracic Electrogram Signals for Detection of Ischemic ST Segment Changes During Normal Sinus and Ventricular Paced Rhythms (2002) (24)
- Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium (2020) (24)
- Efficacy of a novel P-selectin antagonist, rPSGL-Ig for reperfusion therapy in acute myocardial infarction: The RAPSODY trial (2003) (24)
- Commentary: International collaboration needed on device clinical standards (2011) (24)
- Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery. (2008) (24)
- New precompetitive paradigms: focus on cardiac safety. (2009) (24)
- Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study (1994) (23)
- White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) (2017) (23)
- Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction. (1997) (23)
- A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators. (1996) (22)
- Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction. (2019) (22)
- Global cardiovascular device innovation: Japan-USA synergies: Harmonization by Doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions. (2013) (22)
- Implications of ventricular arrhythmia “bursts” with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: A biosignature of direct myocellular injury “downstream of downstream” (2015) (22)
- The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients. (2013) (22)
- Novel electrocardiogram configurations and transmission procedures in the prehospital setting: effect on ischemia and arrhythmia determination. (2006) (22)
- From efficacy to safety concerns: a STEP forward or a step back for clinical research and intercessory prayer? The Study of Therapeutic Effects of Intercessory Prayer (STEP). (2006) (21)
- Clinical application of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty (1993) (21)
- Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) (2018) (21)
- Pediatric cardiovascular safety: challenges in drug and device development and clinical application. (2012) (21)
- Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. (2019) (20)
- Short and long term effect of adjunctive intra-aortic balloon pump use for patients undergoing high risk reperfusion therapy: a meta-analysis of 10 international randomised trials (2013) (19)
- Incremental benefit of 80-lead electrocardiogram body surface mapping over the 12-lead electrocardiogram in the detection of acute coronary syndromes in patients without ST-elevation myocardial infarction: Results from the Optimal Cardiovascular Diagnostic Evaluation Enabling Faster Treatment of Myo (2010) (19)
- Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans. (1992) (19)
- Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire? (2006) (19)
- Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial. (2020) (19)
- Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements. (2018) (19)
- Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials). (2005) (18)
- Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development. (2010) (18)
- Myocardial salvage after failed coronary angioplasty. (1990) (18)
- Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction. (2004) (18)
- Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion (2002) (18)
- The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents. (2007) (18)
- Feasibility and applicability of computer‐assisted myocardial blush quantification after primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction (2010) (18)
- Clinical outcomes in real‐world patients with small vessel disease treated with XIENCE V® everolimus‐eluting stents: One year results from the XIENCE V® USA condition of approval post‐market study (2014) (17)
- Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. (2017) (17)
- Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial). (2008) (17)
- Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry (2019) (17)
- Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial). (2003) (17)
- 1059-23 Cell location may be a primary determinant of safety after myoblast transplantation into the infarcted heart (2004) (16)
- Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. (2010) (16)
- Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents (2020) (16)
- Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). (2018) (16)
- Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI. (2021) (16)
- Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. (2021) (16)
- Poor performance of lead V5 in single- and dual-channel ST-segment monitoring during coronary occlusion. (1988) (16)
- Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database. (2012) (16)
- Drug-eluting stents "deliver heartburn": how do we spell relief going forward? (2007) (15)
- Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk (2020) (15)
- Performance of an automated real-time ST-segment analysis program to detect coronary occlusion and reperfusion. (1996) (15)
- Teaching yoga to seniors: essential considerations to enhance safety and reduce risk in a uniquely vulnerable age group. (2010) (15)
- Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. (2021) (15)
- Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusion. (2008) (15)
- RR-interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction. (2010) (15)
- Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor (2000) (14)
- Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention (2020) (14)
- Electrocardiographic monitoring and coronary occlusion. Fingerprint pattern analysis in dimensions of space, time, and mind. (1989) (14)
- Healing prayer outcomes studies: consensus recommendations. (2003) (14)
- Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events (2019) (14)
- Cardiovascular events and hospital resource utilization pre– and post–transcatheter mitral valve repair in high–surgical risk patients (2017) (14)
- New Medical Technologies in a Cost Containment Environment: Implantahle Antitachyarrhythmia Devices * (1987) (13)
- Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: The Rinspiration international registry (2008) (13)
- Clinical outcomes in real‐world patients with bifurcation lesions receiving Xience V everolimus‐eluting stents: Four‐year results from the Xience V USA study (2016) (12)
- A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy. (2005) (12)
- Embedding clinical interventions into observational studies. (2016) (12)
- Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention: Insights From the PARIS Registry (2019) (12)
- Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial. (2009) (12)
- Cardiac remodeling after large ST-elevation myocardial infarction in the current therapeutic era. (2020) (12)
- Preexcitation and myocardial infarction: conditions with confusing electrocardiographic manifestations. (2008) (12)
- ST-segment monitoring in patients with acute coronary syndromes (2003) (11)
- Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. (2018) (11)
- Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry. (2019) (11)
- Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock. (2020) (11)
- Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies (2020) (11)
- Impact of early, late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction and infarct size as determined by cardiovascular magnetic resonance imaging. (2011) (11)
- The Cardiac Safety Research Consortium enters its second decade: An invitation to participate. (2016) (11)
- Simultaneous comparison of three derived 12-lead ECGs with standard ECG at rest and during percutaneous coronary occlusion. (2004) (11)
- "Mirror-lake" serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction. (2003) (11)
- Correlations Between Preprocedure Mood and Clinical Outcome in Patients Undergoing Coronary Angioplasty (2003) (10)
- Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations. (1993) (10)
- Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty. (1993) (10)
- Advancing medical device innovation through collaboration and coordination of structured data capture pilots: Report from the Medical Device Epidemiology Network (MDEpiNet) Specific, Measurable, Achievable, Results-Oriented, Time Bound (SMART) Think Tank. (2017) (10)
- Radial First: Paradox+Proficiency=Opportunity (2013) (9)
- Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction strategies at rest and during transient myocardial ischemia. (2004) (9)
- Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEMI. (2015) (9)
- Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. (2009) (9)
- Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel‐Coated Devices: Insights From the Veterans Health Administration (2021) (9)
- Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. (2012) (9)
- Should rhythm control be preferred in younger atrial fibrillation patients? (2012) (9)
- Transient electrocardiographic changes of elective coronary angioplasty compared with evolutionary changes of subsequent acute myocardial infarction observed with continuous three-lead monitoring. (1990) (9)
- Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events. (2019) (9)
- Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium (2022) (8)
- Simultaneous platelet glycoprotein IIb/IIIa integrin blockade and front-loaded tissue plasminogen activator in acute myocardial infarction: Results from a randomized trial (1996) (8)
- Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. (2019) (8)
- Ventricular arrhythmia burst is an independent indicator of larger infarct size even in optimal reperfusion in STEMI. (2016) (8)
- What do "we" want and need to know about prayer and healing? (2009) (8)
- Resolution of ST-segment elevation 90 minutes after thrombolysis for acute myocardial infarction predicts outcome: a GUSTO-III substudy (1998) (8)
- Heuristic and logistic principles of ST-segment interpretation in the time domain. Evolution in the context of the TAMI 7 trial design. (1990) (8)
- Electrocardiographic Safety of Cangrelor, a New Intravenous Antiplatelet Agent: A Randomized, Double-blind, Placebo- and Moxifloxacin-controlled Thorough QT Study (2013) (8)
- Determining value of Coordinated Registry Networks (CRNs): a case of transcatheter valve therapies (2019) (8)
- Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study. (2012) (8)
- Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI. (2021) (8)
- Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials. (2019) (8)
- COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial. (2020) (8)
- Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial (2010) (7)
- Myocardial ischemia correlates with reduced fibrinolytic activity following peripheral vascular surgery. (2000) (7)
- Toward a more materialistic medicine: the value of authentic materialism within current and future medical practice. (2011) (7)
- Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction (2019) (7)
- Rationale and design of the AngeLmed for Early Recognition and Treatment of STEMI trial: a randomized, prospective clinical investigation. (2014) (7)
- QRS changes during acute ischemia induced by balloon occlusion of the LAD artery. (1988) (7)
- Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. (2019) (7)
- Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. (2002) (7)
- Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet). (2016) (7)
- Initial experience with a novel coronary rinsing and thrombectomy system: "Rinspiration". (2006) (7)
- Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms. (2019) (7)
- Evolution of an automated ST-segment analysis program for dynamic real-time, noninvasive detection of coronary occlusion and reperfusion. (1992) (6)
- Computer‐assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast‐enhanced cardiovascular magnetic resonance outcomes in patients with ST‐segment elevation myocardial infarction (2011) (6)
- St Segment Changes during Early Myocardial Infarction (1987) (6)
- Clinical utility of the Food and Drug Administration Electrocardiogram Warehouse: a paradigm for the critical pathway initiative. (2005) (6)
- Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty. (1999) (6)
- Growing the path to the patient: an editorial outlook for Alternative therapies. (2000) (6)
- Continuous computer-assisted electrocardiographic monitoring in patients with acute myocardial infarction: early experience (1989) (6)
- Reperfusion ventricular arrhythmia bursts identify larger infarct size in spite of optimal epicardial and microvascular reperfusion using cardiac magnetic resonance imaging (2018) (6)
- Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients (2016) (6)
- Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (6)
- Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial. (2022) (6)
- Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS (2019) (6)
- Dedicated ST-segment monitoring in the CCU after successful coronary angioplasty: incidence and prognosis of silent and symptomatic ischemia (1987) (6)
- Registry Assessment of Peripheral Interventional Devices (RAPID) - Registry Assessment of Peripheral Interventional Devices Core Data Elements. (2018) (6)
- Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study. (2021) (5)
- Prevention of sudden cardiac death in the young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium (2017) (5)
- Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol. (1989) (5)
- Continuous ST-segment monitoring in contemporary acute coronary syndrome patients: the magic of MERLIN-TIMI 36. (2009) (5)
- TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. (2013) (5)
- Erratum: Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC) (Journal of the American College of Cardiology (2015) 65:(931-41)) (2015) (5)
- Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium. (2020) (5)
- Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents. (2014) (5)
- "Hugging balloons" through a single 8-French guide: salvage angioplasty with lytic therapy in the infarct vessel of a 40-year-old man. (1991) (5)
- The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium (2018) (5)
- The impact of autoperfusion on quantitative electrocardiographic parameters of ischemia severity, extent, and "burden" during salvage of elective coronary angioplasty. (1994) (4)
- Conversation in cardiology: Is there a need for clinical trials for the nonhyperemic pressure ratios? (2019) (4)
- Important Considerations for Trials for Peripheral Arterial Disease: Lessons Learned from the Paclitaxel Mortality Signal: A Report on behalf of the Registry Assessment for Peripheral Interventional. (2020) (4)
- Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction. (2021) (4)
- Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients. (2014) (4)
- Instrumentation and Practice Standards for Electrocardiographic Monitoring (2005) (4)
- Focus on the Cardiac Safety Research Consortium (2011) (4)
- Real-time application of continuous 12-lead ST-segment monitoring: 3 case studies. (2000) (4)
- ST-segment recovery as an endpoint in acute myocardial infarction trials. Past, present, and future. (1993) (4)
- Reassessing the clinical significance of ST-segment depression that occurs concomitantly with the ST-segment elevation during acute myocardial infarction with the use of continuous ST-segment analysis. (1994) (4)
- Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI (2022) (4)
- IMPACT OF GENDER ON PATTERNS OF DUAL ANTIPLATELET THERAPY CESSATION AND NON-ADHERENCE: ONE-YEAR RESULTS FROM THE PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS (PARIS), AN OBSERVATIONAL SINGLE-ARM STUDY (2013) (4)
- Quantitation of ischemia during total coronary occlusion with computer-assisted high resolution ST-segment monitoring: effect of collateral flow. (1987) (4)
- Treatment of non-cardiogenic pulmonary edema following cardiopulmonary bypass with veno-venous extracorporeal membrane oxygenation. (1988) (4)
- From ST-elevation myocardial infarction to ST elevation with no myocardial infarction--review and overview of a new horizon of computerized electrocardiographic ischemia detection using high-fidelity implantable devices. (2009) (4)
- Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (4)
- The Abciximab ST-Recovery on AMI (ASTRONAMI) GUSTO V substudy: enhanced early speed, stability, and quality of reperfusion with anti-pletelet augmented thrombolytic therapy for ST-elevation AMI (2002) (4)
- "Take your pill": the role and fantasy of pills in modern medicine. (2014) (3)
- Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women. (2019) (3)
- Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial. (2008) (3)
- Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry (2019) (3)
- CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY (2011) (3)
- Arterial and Venous Access and Hemostasis for PCI (2013) (3)
- Age, STEMI, and Cardiogenic Shock: Never Too Old for PCI? (2019) (3)
- Overview of complementary and alternative medicine Chun-Su Yuan Eric J (2003) (3)
- Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts. (2016) (3)
- Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association–cardiac safety research consortium cosponsored think tank (2017) (3)
- Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury. (2018) (3)
- Abstract 26: Comparison of Medicare Claims with Clinical Trial Outcomes for Follow-up of Older Individuals with Acute Coronary Syndrome (2014) (3)
- Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study (2021) (3)
- Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial. (2019) (3)
- Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy (2022) (3)
- ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT (2018) (3)
- What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2017) (3)
- Noninvasive assessment of patients following coronary artery angioplasty. (1988) (3)
- The comparison of epicardial focused ultrasound circumferential pulmonary vein ablation and BOX ablation—results from experimental acute atrial fibrillation (2012) (3)
- Performance Goal Criteria for Device Evaluation in Lower Extremity Peripheral Vascular Intervention and the Need for Standardized Data Structure: What Is the Sound of One Hand Clapping? (2018) (3)
- The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study. (2011) (3)
- Transradial PCI in women: problem solved or clinical equipoise? (2011) (3)
- From signal/noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoring. (1994) (3)
- Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients. (2020) (3)
- COMPARISON OF RATES OF BLEEDING AND VASCULAR COMPLICATIONS BEFORE, DURING, AND AFTER TRIAL ENROLLMENT IN THE SAFE-PCI TRIAL FOR WOMEN (2018) (3)
- 2: Early Objective Identification of Chest Pain Patients at Very Low Risk of 30-Day Adverse Outcomes (2009) (2)
- Cyclic coronary flow: defining preinfarction angina at the crossroads of unstable angina and myocardial infarction. (2001) (2)
- MAGNITUDE AND DURATION OF INTRACARDIAC ST-SEGMENT CHANGES FOR CONFIRMED CLINICAL EVENTS: FIRST IN-MAN EXPERIENCE (2012) (2)
- Current Approaches to Prevention and Management of Reperfusion Injury (2012) (2)
- Thrombin and fibrin activity in patients treated with enoxaparin, ticlopidine and aspirin versus the conventional coumadin regimen after elective stenting: The ENTICES trial (1996) (2)
- A Path Forward for Regenerative Medicine: Navigating Regulatory Challenges Summary of Findings From the Cardiac Safety Research Consortium/Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine (2018) (2)
- Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis. (2008) (2)
- Japan-USA orbital atherectomy for calcific coronary lesions: COAST study, Hharmonization by Doing proof-of-concept. (2021) (2)
- Compliance of balloon material does not effect angiographic dissection rate. Results from the CRAC(Compliant Related Acute Complication) study (1996) (2)
- WHITE BLOOD CELL COUNT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE CONTEMPORARY ERA: INSIGHTS FROM THE PARIS STUDY (2017) (2)
- Evidence strength in FDA premarket approval of cardiovascular devices. (2010) (2)
- Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs (2020) (2)
- ASSOCIATION OF STENT THROMBOSIS AND PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS: SIX MONTH RESULTS OF THE PARIS REGISTRY (2012) (2)
- The East–West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug‐eluting stent study cohorts (2018) (2)
- 737–6 Combining Myoglobin and Clinical Variables for Assessing Coronary Reperfusion After Thrombolytic Therapy (1995) (2)
- QUANTIFICATION OF AMPLITUDE, SPEED AND COMPLETENESS OF ST-SEGMENT RECOVERY AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: WHAT IS THE “BEST ST” RECOVERY TO PREDICT CLINICAL OUTCOME? (2010) (2)
- Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies (2021) (2)
- Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. (2022) (2)
- Learning to walk before we run: the mechanics of medical intervention for peripheral arterial disease. (2011) (2)
- Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus‐eluting stents (2020) (2)
- SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention. (2020) (2)
- ST-segment parameters and the GUSTO-I mortality model: another risk-stratification tool in acute myocardial infarction (1998) (1)
- One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape (2022) (1)
- Maximum likelihood estimation of time to first event in the presence of data gaps and multiple events (2016) (1)
- The first ISCE board of [ldquo ]Trustees[rdquo ] overview panel session: Ischemia monitoring, state of the art (2002) (1)
- Drug eluting stents and the critical path initiative: Evolving paradigms for safety evaluation. (2007) (1)
- Conversations in Cardiology (2014) (1)
- Abstract 4156: Comparison of Sirolimus-Eluting NEVOTM Stents With Paclitaxel-eluting CoStarTM Stents and Paclitaxel-eluting Taxus LiberteTM Stents: Insights From Intravascular Ultrasound Analysis of the Res-elution I and Costar II Trials (2009) (1)
- TCT-539 Clinical outcomes in high bleeding risk patients undergoing complex PCI with the Xience everolimus eluting stent: a patient-level pooled analysis from four Xience post-approval trials (2018) (1)
- Patients Accept Mortality Risk for Improvements in Physical Functioning in Secondary Mitral Regurgitation (2019) (1)
- 1000–37 The “Long Long” Balloon Pilot: Dilatation of Class C Coronary Lesions Using Slow, Oscillating, Prolonged Inflation of 40 mm Balloons (1995) (1)
- Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement. (2017) (1)
- Relax into Yoga for Seniors: An Evidence-Informed Update for Enhancing Yoga Practice Benefits by Reducing Risk in a Uniquely Vulnerable Age Group (2021) (1)
- Simultaneous restenosis of Taxus and Cypher drug-eluting stents. (2006) (1)
- Abstract 18405: Low Clinical Event Rates in Real-World Patients with Bifurcation Lesions Receiving XIENCE V® Everolimus-Eluting Stents: One-Year Results from the XIENCE V USA Study (2010) (1)
- Cardiac Safety Research Consortium (CSRC) (2015) (1)
- Mitchell W. Krucoff, MD. The MANTRA Study Project. Interview by Bonnie Horrigan. (1999) (1)
- ACCF Complementary Medicine Expert Consensus Document — Online Appendices Integrating Complementary Medicine Into Cardiovascular Medicine (2005) (1)
- SURVIVAL IN PATIENTS WITH MODERATE OR SEVERE MITRAL REGURGITATION AT HIGH RISK FOR SURGERY TREATED WITH AND WITHOUT THE MITRACLIP: A PROPENSITY MATCHED COMPARISON (2012) (1)
- Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. (2022) (1)
- The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent. (2021) (1)
- Standards need international collaboration (2011) (1)
- Abstract 1768: Effect of Pre-Hospital 12-Lead ST-Segment Monitoring on Time to Treatment in Acute Coronary Syndrome: The ST SMART Study (2006) (1)
- Ventricular arrhythmia bursts following primary percutaneous coronary intervention for acute myocardial infarction: correlations with microvascular obstruction and final infarct size using CMR (2013) (1)
- Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non-ST-elevation acute coronary (2017) (1)
- Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. (2022) (1)
- An Academic ECG Core Lab Perspective of the FDA Initiative for Digital ECG Capture and Data Management in Large-Scale Clinical Trials* (2005) (1)
- Healing Moves: How to Cure, Relieve, and Prevent Common Ailments with Exercise (2000) (1)
- Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents. (2012) (1)
- Quantitative ST-segment recovery following angiographically successful angioplasty: a useful warning of early complications. (1988) (1)
- Unstable infarct artery. Quantification across angiographic subgroups using continuous digital 12-lead ST-segment recovery analysis. (1992) (1)
- Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. (2022) (0)
- Reply: Transradial PCI in Women: Zeroing in on Crossovers. (2015) (0)
- Reply: Improving the Patient Relevance and Generalizability of TAVR Core Data Elements. (2022) (0)
- Evaluation and Treatment of Patients With Lower Extremity Peripheral ArteryDisease (2015) (0)
- The first ISCE Board of "Trustees" overview panel session: ischemia monitoring, state of the art. International Society of Computerized Electrocardiology. (2002) (0)
- TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. (2016) (0)
- Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women : Results of the SAFE-PCI for Women Quality-of-Life Substudy (2015) (0)
- “Over The Shoulder” Guidewire Manipulation Through An Angulated Stenosis Adjacent To A Coronary Aneurysm During High Risk Percutaneous Transluminal Angioplasty (1992) (0)
- The use of digital real-time 12-lead ST segment trends in the management of acute myocardial infarction patients during helicopter transport and early hospitalization (1989) (0)
- CONTINUOUS 12-LEAD ST-SEGMENT RECOVERY PREDICTS OUTCOME IN ACUTE MYOCARDIAL INFARCTION BETTER THAN SNAPSHOT ANGIOGRAMS OF TIMI FLOW (1998) (0)
- Abstract 2398: The Role of RR-Interval Variability Preceding Ventricular Fibrillation in ST Elevation Acute Myocardial Infarction (2007) (0)
- ASSOCIATIONS BETWEEN DIFFERENT MODES OF DAPT CESSATION AND MAJOR ADVERSE EVENTS AT 6 MONTHS AND BEYOND: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- Comparison of published ST recovery analysis methods to predict clinical outcome in acute myocardial infarction using a single digital continuous 12-lead ECG data set (1999) (0)
- Cardiovascular Disease in the Young : Endorsed by the American Heart Association Scientific Statement From the Councils on Cardiovascular Practice Standards for Electrocardiographic Monitoring in Hospital Settings : An Print (2004) (0)
- Pharmacodynamic Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: A Prespecified Subanalysis of The COMPARE CRUSH Trial (2021) (0)
- Coronary heart disease Reperfusion ventricular arrhythmia ‘ bursts ’ predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction (2009) (0)
- Registry Assessment of Peripheral Interventional Devices Objective Performance Goals for Superficial Femoral and Popliteal Artery Peripheral Vascular Interventions. (2020) (0)
- Abstract 14749: Anatomic and Physiologic Determinants of the Area-at-Risk Differentiate in Range of Infarct Size among Patients Undergoing Primary Percutaneous Coronary Intervention (2012) (0)
- Changes in coronary patency with continuous 12-lead st segment monitoring during transport and early management of acute myocardial infarction patients (1989) (0)
- Device implementation, validation, and application assessment of two continuous 12-lead ECG monitors during percutaneous transluminal coronary angioplasty: description of the validation method and implications for clinical trials. (1998) (0)
- VENTRICULAR ARRHYTHMIA BURSTS FOLLOWING PRIMARY PCI FOR ACUTE MYOCARDIAL INFARCTION: CORRELATIONS WITH CMRI OF MICROVASCULAR OBSTRUCTION AND FINAL INFARCT SIZE (2013) (0)
- CLOPIDOGREL WITH AND WITHOUT PROTON PUMP INHIBITOR USE: A PARIS REGISTRY ANALYSIS (2014) (0)
- From HIRMIT to the Cape May Lighthouse. Revascularization reconsidered in very high risk patients at the Duke Heart Center. (1991) (0)
- Twelve lead real-times ST segment monitoring during helicopter transport of acute myocardial infarction patients after thrombolytic therapy (1989) (0)
- AS-46: Randomized Comparison of Primary Percutaneous Coronary Intervention with Combined Proximal Embolic Protection and Thrombus Aspiration versus Primary Percutaneous Coronary Intervention Alone in ST-segment Elevation Myocardial Infarction (2009) (0)
- Editorial: Radial to Coronary: Ideal Catheter for the Ideal Approach. (2017) (0)
- Predictable And SuStainable Implementation Of National Cardiovascular Registries Infrastructure: A Think Tank Report from MDEpiNet (2015) (0)
- Global medical device clinical trials involving both the United States and Japan: Key considerations for development, regulatory approval, and conduct. (2023) (0)
- 1003-93 Outcomes prediction with continuous 12-lead ST-segment recovery in ST elevation myocardial infarction: Similarities or differences with thrombolytic versus direct stenting populations? (2004) (0)
- Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank. (2020) (0)
- TCT CONNECT-64 Impact of DAPT Cessation in High Bleeding-Risk Patients Undergoing PCI: Insights From the PARIS Registry (2020) (0)
- Conversation in cardiology: Should FFR and IVUS be counted as PCI? (2013) (0)
- Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women: Results of the SAFE-PCI for Women Quality-of-Life Substudy Short title: Hess et al.: QOL in SAFE-PCI for Women (2015) (0)
- New applications of computer assisted ST segment analysis (1986) (0)
- mproved Speed and Stability f ST-Segment Recovery With educed-Dose Tenecteplase and Eptifibatide ompared With Full-Dose Tenecteplase for cute ST-Segment Elevation Myocardial Infarction (2016) (0)
- Overlapping paclitaxel elating stents: Early outcomes in the COSTAR II study (2006) (0)
- Abstract 84: Impact of Education on Dual Antiplatelet Therapy Adherence (2012) (0)
- Opening the window of facilitated percutaneous coronary intervention in acute infarction: The role of combined IIb/IIIa inhibition and thrombolytic therapy (2003) (0)
- The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized Trial. (2018) (0)
- GENDER-BASED CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING XIENCE V® EVEROLIMUS-ELUTING STENTS: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY (2011) (0)
- Reduction of ischemic ST deviation and regional wall motion dysfunction during PTCA of the Left Anterior Descending Coronary Artery (LAD) with Synchronized Coronary Sinus Retroperfusion (SRP) (1996) (0)
- Performance of an A u t o m a t e d Real-t ime ST-Segment Analysis Program to Detect Coronary Occlusion and Reperfusion (2005) (0)
- Electrocardiographic patterns of impending coronary closure independent of unstable anginal symptoms (1989) (0)
- Novel Design Changes in DES Not Necessarily Better until Proven So (2012) (0)
- PREDICTION OF DEATH AND CONGESTIVE HEART FAILURE USING MULTIPLE CONCOMITANT ANGIOGRAPHIC BIOCHEMICAL AND ELECTROCARDIOGRAPHIC BIOMARKERS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2011) (0)
- Restenosis, statistics, and reasonable inferences. Authors' replay (2006) (0)
- Comparison of Primary Percutaneous oronary Intervention With Combined Proximal mbolic Protection and Thrombus Aspiration Versus rimary Percutaneous Coronary Intervention Alone n ST-Segment Elevation Myocardial Infarction (0)
- Evaluation of paclitaxel eluting stents in single and multivessel coronary artery disease using established and novel stent platforms: An interim analysis of the randomized, blinded COSTAR II trial (2006) (0)
- Abstract 14862: Prediction of Myocardial Infarct Size Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention (2011) (0)
- ST-elevation no myocardial infarction (2017) (0)
- P1022Upstream therapy using preoperative renin-angiotensin system inhibitors in prevention of postoperative atrial fibrillation and adverse events: a collaborative pooled-analysis over 27,000 patients (2019) (0)
- Response to letter regarding article, "The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry". (2015) (0)
- INCIDENCE, PATTERNS AND ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND RISK FOR ADVERSE EVENTS IN HIGH-RISK PATIENTS: INSIGHTS FROM THE PARIS REGISTRY (2018) (0)
- Abstract 2032: Mechanistic and Prognostic Implications of "Burst" Ventricular Arrhythmias and Their Precise Timing after TIMI 3 Reperfusion in Anterior ST Elevation Myocardial Infarction (2007) (0)
- ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND MACE DUE TO STOPPING ONE OR BOTH DRUGS: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- Analysis intheTAMI7Study Performance ofa Noninvasive MethodforReal-Time Detection ofFailed Myocardial Reperfusion (2011) (0)
- Abstract 19050: Does Type of Culprit Lesion Matter in Patients with Acute Coronary Syndrome and Prior Coronary Artery Bypass Graft Surgery Undergoing Percutaneous Coronary Intervention? (2012) (0)
- Alvin C. Wyman, M.D (1984) (0)
- Defining QT / QTc Prolongation During ST-Elevation Myocardial Infarction and Reperfusion (2014) (0)
- Abstract 18402: Impact of the Use of Different Bleeding Scales on the Rate of 6-Month Bleeding After PCI: Results from the PARIS Registry (2012) (0)
- Abstract 16705: Lower Education Level is Associated with Non-Adherence to Dual Antiplatelet Therapy After PCI: 6-Month Results from PARIS (2012) (0)
- Abstract 15433: Prevalence and Natural History of Moderate or Severe Mitral Regurgitation: an Observational Study from a Single Center (2011) (0)
- Treatment of smaller coronary vessels with XIENCE V® everolimus-eluting stents in real-world patients: 1-year clinical outcomes from the XIENCE V USA study (2011) (0)
- Abstract 20347: Low Clinical Event Rates in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V(R) Everolimus-Eluting Stents: One-Year Results from the XIENCE V USA Study (2010) (0)
- CRT-100.35 Predictors of Early Myocardial Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPARE CRUSH Trial (2022) (0)
- Clinical outcomes in treatment of chronic total occlusions with the XIENCE V everolimus-eluting stent system in real-world patients: one-year pooled results from the XIENCE V USA and SPIRIT V studies (2013) (0)
- TCT-225 Impact of Age on the Disruption of Dual Antiplatelet Therapy: Analysis from the PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented) Patients Registry (2015) (0)
- Device and Procedure Relatedness: Viewpoint From Members of the ARC Steering Group. (2022) (0)
- OralBleeding and the Hazards of AnticoagulationTCT-89 Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry (2017) (0)
- Direct stenting versus stenting after predilatation in STEMI patients with high thrombus burden: a subanalysis from the randomized COMPARE CRUSH trial (2022) (0)
- Recurrence of ST elevation after early reperfusion as a marker of prognosis in ST elevation infarction (2003) (0)
- Novel applications of ECG monitoring for the quantification of noetic phenomena (1999) (0)
- TICAGRELOR MONOTHERAPY AFTER PCI ACROSS THE SPECTRUM OF HIGH-RISK PATIENTS: A DEEP DIVE INTO THE TWILIGHT TRIAL (2022) (0)
- Abstract 12989: Generalizability of Quantitative Angiographic In-Segment Late Lumen Loss Imaging in Eastern and Western Populations: Can We Facilitate Global Drug Eluting Stent Evaluation? (2014) (0)
- Abstract 20469: Predictors of 1-Year Clinical Outcomes in Real World Patients from XIENCE V(R) USA Study. (2010) (0)
- The Monitoring and Actualization of Noetic TRAining the MANTRA Study, a randomized controlled study of healing interventions. (1997) (0)
- TCT-674 Implication of peri-procedural biomarker elevation after stent implantation: analysis from the pooled XIENCE V trials (2012) (0)
- TCT-455 Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis with the XIENCE V Everolimus-Eluting Stent (2013) (0)
- P511Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry (2017) (0)
- Reporting an Erratum in the article, “Preexcitation and Myocardial Infarction: Conditions with Confusing Electrocardiographic Manifestations”, November/December issue (41/6) (2009) (0)
- EVALUATION OF THE ACADEMIC RESEARCH CONSORTIUM HIGH BLEEDING RISK DEFINITION IN PATIENTS TREATED WITH DRUG-COATED STENTS AND BARE-METAL STENTS FROM THE LEADERS FREE I & II TRIALS (2020) (0)
- TCT-304 Long term clinical outcomes in acute coronary syndrome patients at high bleeding risk undergoing PCI with implantation of everolimus-eluting stents: Results from the Patient-Level Pooled Analysis of EES Post Approval Studies. (2018) (0)
- Performance of a novel statistical filter to compensate for data gaps during continuous ST-segment monitoring (2005) (0)
- TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES. (2016) (0)
- A Comparison of Static Serial vs Continuous ST-Segment Recovery to Predict Outcome After Lytics for MI (1998) (0)
- Abstract 11123: Outcomes After Percutaneous Coronary Intervention for Patients With Stable Coronary Disease and Left Ventricular Systolic Dysfunction (2014) (0)
- Prognostic significance of ST segment monitoring early after myocardial infarction: GUSTO ECG substudy (1996) (0)
- Conversations in cardiology: Late career transitions—Retool, retire, refocus (2022) (0)
- Meeting Report ESC Forum on Drug Eluting Stents European Heart House, Nice, 27 – 28 2007 (2009) (0)
- TCT-645 Cardiovascular Events and Hospital Resource Utilization Pre and Post Transcatheter Mitral Valve Repair in High Surgical Risk Patients. (2016) (0)
- TCT-421 Prevalence and treatment patterns for in-stent restenosis: A single center report from the Duke Databank for Cardiovascular Disease (2017) (0)
- ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike. (2022) (0)
- Stent Thrombosis in BMS and DES More issues than answers (0)
- The MANTRA II study – Authors' reply (2005) (0)
- Discussion of: Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies (2007) (0)
- TCT-844 Long term risk for major bleeding and ischemic events after PCI with implantation of everolimus-eluting stents: A Pooled-level Analysis of 8,020 Patients (2018) (0)
- Reperfusion arrhythmia bursts predict larger infarct size in STEMI patients undergoing primary percutaneous coronary intervention despite optimal epicardial and microvascular flow (2013) (0)
- The incremental prognostic value of therapy responsive continuous 12-lead ST-segment variables to baseline clinical descriptors for the prediction of clinical outcome after acute myocardial infarction (1999) (0)
- TCT-484: Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial (2016) (0)
- THE IMPACT OF RIGOROUS QUALITY IMPROVEMENT ON 3D ECHOCARDIOGRAPHY IMAGE AND DATA QUALITY IN AN INTERNATIONAL MULTISITE RANDOMIZED TRIAL (2017) (0)
- Prayer and Cardiovascular Disease (2004) (0)
- TEMPORAL ASSOCIATIONS BETWEEN TIME AFTER PERCUTANEOUS CORONARY INTERVENTION, DUAL ANTIPLATELET THERAPY CESSATION AND STENT THROMBOSIS IN THE CONTEMPORARY PCI ERA: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- The impact of XIENCE V on health status in a variety of angiographic subsets using the Seattle Angina Questionnaire (2010) (0)
- AS-3: Immediate ST-Segment Resolution Is Associated with Left Ventricular Function and Infarct Size Measured by Cardiovascular Magnetic Resonance in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention (2009) (0)
- In memorium: Nancy B. Wagner, 1949–1991 (1991) (0)
- TCT-110 Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry (2018) (0)
- TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS. (2016) (0)
- ST Segment Monitoring Substudy patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I Prognostic significance of ST segment shift early after resolution of ST elevation in (2011) (0)
- TICAGRELOR MONOTHERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION. A PRESPECIFIED TWILIGHT SUBSTUDY (2021) (0)
- Transluminal Coronary Angioplast (2005) (0)
- TCT-45 Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study (2012) (0)
- Toward a better system for the sustainable development of objective performance goals for peripheral vascular interventions. (2021) (0)
- Permanently implantable diagnostic computerized devices: where is the regulatory rar? (2004) (0)
- DUAL ANTIPLATELET THERAPY (DAPT) CESSATION AND CARDIOVASCULAR RISK IN RELATION TO AGE: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2019) (0)
- Chapter 22 – Prayer and Cardiovascular Disease (2005) (0)
- Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents : Primary Endpoint Results from the Dual Antiplatelet Therapy Study (2014) (0)
- P2262Long-term safety and efficacy of the xience everolimus eluting stent in patients at high bleeding risk: a patient-level pooled analysis from four xience post-approval trials (2018) (0)
- PREDICTING MAJOR ADVERSE CARDIAC EVENTS AND INFARCT SIZE USING ST-SEGMENT RESOLUTION AS A CONTINUOUS RATHER THAN A DICHOTOMOUS VARIABLE IN PATIENTS ACHIEVING THROMBOLYSIS IN MYOCARDIAL INFARCTION FLOW GRADE III AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFA (2010) (0)
- Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock. (2022) (0)
- TCT CONNECT-376 A Novel Machine Learning Algorithm Enhances Prediction of Target Lesion Failure: An Analysis of 4,983 Patients From the XIENCE V USA Database (2020) (0)
- Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction - One-year follow-up results of the COMPARE CRUSH trial: One-year results from the COMPARE CRUSH trial. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mitchell W. Krucoff?
Mitchell W. Krucoff is affiliated with the following schools: